Cargando…

Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision

Detalles Bibliográficos
Autores principales:	Ecke, Thorsten H., Le Calvez-Kelm, Florence, Otto, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145419/ https://www.ncbi.nlm.nih.gov/pubmed/35628431 http://dx.doi.org/10.3390/ijms23105620

Ejemplares similares

Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
por: Ecke, Thorsten H., et al.
Publicado: (2020)

Illumination of a Vision 2020—Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions—Dream or Nightmare?
por: Ecke, Thorsten H., et al.
Publicado: (2020)

Illumination of a Vision—How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research
por: Ecke, Thorsten H., et al.
Publicado: (2017)

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
por: Zvereva, Maria, et al.
Publicado: (2020)

Endoscopic ultrasound's vision: Probing our way to NOTES
por: Sun, Siyu
Publicado: (2014)

UBC(®) Rapid Test—A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study
por: Ecke, Thorsten H., et al.
Publicado: (2018)

COVID-19 Has Provided 20/20 Vision Illuminating Our Nation’s Health Crises
por: Katzman, Joanna G, et al.
Publicado: (2020)

Telocytes subtypes in human urinary bladder
por: Vannucchi, Maria-Giuliana, et al.
Publicado: (2014)

Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer
por: Wucherpfennig, Sophie, et al.
Publicado: (2021)

Vision under mesopic and scotopic illumination
por: Zele, Andrew J., et al.
Publicado: (2015)

Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder
por: Rabien, Anja, et al.
Publicado: (2018)

Our vision
Publicado: (2019)

Our vision
por: Hodak, Hélène
Publicado: (2019)

The Electric Illumination of the Bladder and Urethra
Publicado: (1888)

The Electric Illumination of the Bladder and Urethra
Publicado: (1888)

The Electric Illumination of the Bladder and Urethra
Publicado: (1888)

Molecular palaeontology illuminates the evolution of ecdysozoan vision
por: Fleming, James F., et al.
Publicado: (2018)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Effect of Illumination on Colour Vision Testing with Farnsworth-Munsell 100 Hue Test: Customized Colour Vision Booth versus Room Illumination
por: Zahiruddin, Kowser, et al.
Publicado: (2010)

Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
por: Hasanau, Tsimur, et al.
Publicado: (2022)

Illumination-Based Synchronization of High-Speed Vision Sensors
por: Hou, Lei, et al.
Publicado: (2010)

Illumination-Based Color Reconstruction for the Dynamic Vision Sensor
por: Cohen, Khen, et al.
Publicado: (2023)

The Error of our Ways
por: Henney, Kevlin
Publicado: (2019)

Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC(®) Rapid Test in Bladder Cancer
por: Oehr, Peter, et al.
Publicado: (2020)

A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer
por: Khan, Safayat Mahmud, et al.
Publicado: (2023)

Diagnostic and prognostic role of urinary collagens in primary human bladder cancer
por: Miyake, Makito, et al.
Publicado: (2017)

TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region
por: Pakmanesh, Hamid, et al.
Publicado: (2022)

“Bladder Effect” - An Urodynamic Parameter to Distinguish Subtypes of Urinary Incontinence in Women
por: Stojchevski, Sasho, et al.
Publicado: (2018)

Are We Executing Our Vision?
por: Raju, Sri, et al.
Publicado: (2023)

Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment
por: Ecke, Thorsten H., et al.
Publicado: (2022)

Finding our way home
por: Dagnone, J Damon
Publicado: (2017)

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2021)

The prognostic value of histological subtype in patients with metastatic bladder cancer
por: Chen, Cheng, et al.
Publicado: (2017)

Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
por: Grotenhuis, Anne J., et al.
Publicado: (2014)

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy
por: Ecke, Thorsten H., et al.
Publicado: (2020)

Bladder Reconstruction with Human Amniotic Membrane in a Xenograft Rat Model: A Preclinical Study
por: Barski, Dimitri, et al.
Publicado: (2017)

The lost art of finding our way
por: Huth, Edward John
Publicado: (2013)

Finding Our Way through Phenotypes
por: Deans, Andrew R., et al.
Publicado: (2015)

Cycling our way to fit fat
por: Townsend, Logan K., et al.
Publicado: (2017)

Simultaneous multi-analyte urinary protein assay for bladder cancer detection
por: Rosser, Charles J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0d83c05ljvsmfnuvd5ioa54ti0